Arterial Access Articles & Analysis
10 news found
” About Silk Road Medical’s TCAR Procedure with the ENROUTE Transcarotid Neuroprotection and Stent System TransCarotid Artery Revascularization is our clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. ...
Leveraging the versatility of its technology platform, which can be used to improve many types of implants, Xeltis initiated the development of three types of cardiovascular implants: pulmonary heart valves, coronary artery bypass graft and haemodialysis access grafts, the roll-out of which is set to be accelerated by this EIB ...
Nationally there is a trend moving towards radial artery access versus femoral artery access for endovascular procedures and Q’Apel Medical is leading the way. ...
The presentation: Expansion of Transcarotid Artery Revascularization to Standard Risk Patients for Treatment of Carotid Artery Stenosis, will be shared by Dr. ...
(Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, recently announced the opening of a new office in Plymouth, Minnesota, to accommodate growing demand for TransCarotid Artery Revascularization (TCAR) and to access the local talent pool of aspiring and experienced med tech professionals. ...
The valve’s unique design also enables anatomical valve alignment, which facilitates future access to the coronary arteries and beneficial hemodynamics, both of which are significant clinical advantages for the treatment of aortic regurgitation and aortic stenosis. ...
” JAMA Network Open is an international, peer-reviewed, open access, general medical journal with one of the highest Impact Factors among all open access general medicine journals. ...
BIOMODEX, a pioneering digital health company that offers a unique and enhanced 3D printed solution for physician training, announced today the company has partnered with two of the top medical centers in France and a world-class health system in the United States to develop EVIAS Plus - an innovative training solution for treatment of ischemic stroke. Ischemic stroke accounts for about 87 ...
ByBIOMODEX
” Previously, as Clair explained in his presentation, these no-option patients would have received a “dead-end angioplasty” in an effort to revascularise the peroneal artery and promote healing, but the chances of success in this situation are very low. ...
The trial evaluated 23 patients at a single site and assessed the safety and effectiveness of the Large Bore Closer device in sealing femoral arterial access sites at the completion of percutaneous endovascular procedures performed through 10- to 16-F introducer sheaths. The primary safety endpoint is a composite of 60-day access site ...